GRIFOLS | GRF - Cost Of Sales



GRIFOLS reported EUR1.15B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Alcon AG USD 1.21B 118M Jun/2025
Almirall EUR 195.09M 100.89M Jun/2025
Amadeus IT EUR 543.1M 131.4M Jun/2025
Amarin USD 16.89M 18.51M Mar/2025
argenx SE USD 110.75M 29.94M Jun/2025
AstraZeneca USD 2.47B 232M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Cie Automotive EUR 1.09B 84.17M Dec/2024
Demant DKK 2.71B 46M Jun/2025
Ence Energia y Celulosa EUR 128.7M 31.4M Jun/2025
Essilor EUR 5.31B 2.79B Jun/2025
Ferrovial EUR 747M 132M Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
Galapagos EUR 4.71M 9.02M Jun/2025
Genmab DKK 57M 15M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
GRIFOLS EUR 1.15B 56.19M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Inditex EUR 4.01B 1.14B Apr/2025
Merck EUR 2.23B 93M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Philips EUR 2.33B 79M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
Smith & Nephew USD 870M 41M Jun/2025
UCB EUR 901M 50M Dec/2024
Viscofan EUR 91.82M 3.99M Jun/2025